Feb. 05, 2020: The U.S. FDA moved closer on Tuesday to formulating standardized testing of talc-based products for the presence of toxic asbestos fibers.
Experts...
Feb. 05, 2020: VIVUS, a biopharmaceutical company announced that the U.S.FDA has approved the sNDA for an improved formulation of PANCREAZE® (pancrelipase) Delayed Release Capsules...
Feb. 05, 2020: Alector, Inc., a clinical-stage biotechnology company pioneering immuno-neurology announced that the U.S.FDA has granted Fast Track designation to AL101 for the...
Feb. 05, 2020: BioXcel Therapeutics announced that its IND
application for BXCL501, the Company’s proprietary sublingual thin-film formulation
of dexmedetomidine, has received clearance from the U.S.FDA...
Feb 04, 2020: MorphoSys AG announced the initiation of an expanded access program (EAP) in the U.S. for tafasitamab, an investigational anti-CD19 antibody.
The...
GRADUATE PHARMACY APTITUDE TEST (GPAT) is a national level entrance
examination for entry into M.Pharm programmes. Till 2018, it was conducted by
All India Council for...
Feb 4, 2020: Vituro Health announce that it, in partnership with Choice Diagnostic Imaging, successfully completed the first three TULSA-PRO® treatments to ablate prostate tissue in patients...
Feb 3, 2020:Accumen Inc.
announced that its 3DR Labs, LLC company is partnering with Resonance Health
Limited in order to provide FerriSmart magnetic resonance imaging- (MRI-)...
Feb 04, 2020: U.S Food and Drug Administration issued an emergency use authorization (EUA) to enable emergency use of the Centers for the Disease Control and...